HER2 Support Group Forums

HER2 Support Group Forums (https://her2support.org/vbulletin/index.php)
-   General Cancer News (https://her2support.org/vbulletin/forumdisplay.php?f=45)
-   -   ALKBH3 regulates glycolysis and doxorubicin resistance in triple negative breast canc (https://her2support.org/vbulletin/showthread.php?t=71455)

News 07-12-2025 09:38 AM
ALKBH3 regulates glycolysis and doxorubicin resistance in triple negative breast canc
 
This new article publication from Acta Pharmaceutica Sinica B, discusses how ALKBH3-regulated m1A of ALDOA potentiates glycolysis and doxorubicin resistance of triple negative breast cancer cells.

More...


All times are GMT -7. The time now is 09:32 AM.

Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021